Peter Mueller - Net Worth and Insider Trading
Peter Mueller Net Worth
The estimated net worth of Peter Mueller is at least $83 Million dollars as of 2024-11-13. Peter Mueller is the EVP, Global R&D, CSO of Vertex Pharmaceuticals Inc and owns about 169,088 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $83 Million. Peter Mueller is also the Director of BioXcel Therapeutics Inc and owns about 168,320 shares of BioXcel Therapeutics Inc (BTAI) stock worth over $111,933. Details can be seen in Peter Mueller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Mueller has not made any transactions after 2019-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Mueller
Peter Mueller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Mueller owns 2 companies in total, including BioXcel Therapeutics Inc (BTAI) , and Vertex Pharmaceuticals Inc (VRTX) .
Click here to see the complete history of Peter Mueller’s form 4 insider trades.
Insider Ownership Summary of Peter Mueller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTAI | BioXcel Therapeutics Inc | 2019-08-23 | director |
| VRTX | Vertex Pharmaceuticals Inc | 2014-06-16 | CSO & SVP Drug Discovery |
Peter Mueller Latest Holdings Summary
Peter Mueller currently owns a total of 2 stocks. Among these stocks, Peter Mueller owns 169,088 shares of Vertex Pharmaceuticals Inc (VRTX) as of June 16, 2014, with a value of $83 Million and a weighting of 99.87%. Peter Mueller also owns 168,320 shares of BioXcel Therapeutics Inc (BTAI) as of August 23, 2019, with a value of $111,933 and a weighting of 0.13%.
Latest Holdings of Peter Mueller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2014-06-16 | 169,088 | 490.00 | 82,853,120 |
| BTAI | BioXcel Therapeutics Inc | 2019-08-23 | 168,320 | 0.67 | 111,933 |
Holding Weightings of Peter Mueller
Peter Mueller Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Mueller has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 7,500 shares on June 16, 2014, which brought Peter Mueller around $512,325.
According to the SEC Form 4 filings, Peter Mueller has made a total of 0 transactions in BioXcel Therapeutics Inc (BTAI) over the past 5 years. The most-recent trade in BioXcel Therapeutics Inc is the acquisition of 1,554 shares on August 23, 2019, which cost Peter Mueller around $14,514.
Insider Trading History of Peter Mueller
- 1
Peter Mueller Trading Performance
GuruFocus tracks the stock performance after each of Peter Mueller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Mueller is 20.75%. GuruFocus also compares Peter Mueller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Mueller within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Mueller's insider trading performs compared to the benchmark.
Performance of Peter Mueller
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.66 | | | | | |
| Relative Return to S&P 500(%) | 12.15 | | | | | |
Peter Mueller Ownership Network
Ownership Network List of Peter Mueller
Ownership Network Relation of Peter Mueller
Peter Mueller Owned Company Details
What does BioXcel Therapeutics Inc do?
Who are the key executives at BioXcel Therapeutics Inc?
Peter Mueller is the director of BioXcel Therapeutics Inc. Other key executives at BioXcel Therapeutics Inc include CHIEF COMMERCIAL OFFICER Matthew T. Wiley , Chief Financial Officer Richard I Steinhart , and Chief Scientific Officer Frank Yocca .
BioXcel Therapeutics Inc (BTAI) Insider Trades Summary
Over the past 18 months, Peter Mueller made no insider transaction in BioXcel Therapeutics Inc (BTAI). Other recent insider transactions involving BioXcel Therapeutics Inc (BTAI) include a net sale of 1,503,378 shares made by Vimal Mehta , a net sale of 13,972 shares made by Richard I Steinhart , and a net sale of 10,366 shares made by Javier Rodriguez .
In summary, during the past 3 months, insiders sold 36,432 shares of BioXcel Therapeutics Inc (BTAI) in total and bought 0 shares, with a net sale of 36,432 shares. During the past 18 months, 1,550,438 shares of BioXcel Therapeutics Inc (BTAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,550,438 shares.
BioXcel Therapeutics Inc (BTAI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioXcel Therapeutics Inc Insider Transactions
Peter Mueller Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Mueller. Currently GuruFocus does not have mailing address information for Peter Mueller.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
